OraSure Technologies, Inc. (OSUR)

NasdaqGS • Currently down 0.10 (-2.62%) in today's trading session

1 member of Congress has disclosed 12 trades in OraSure Technologies, Inc. (OSUR) via STOCK Act filings. The most recent disclosure was a sale by Tom Malinowski on 23 February 2021. Aggregate disclosed activity totals roughly $292K in sales (midpoint estimates from bracketed disclosure amounts).

OraSure Technologies, Inc. is currently trading at $3.71, positioned at 65% of its 52-week range ($2.08 – $4.58).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$3.71
24h Change
-0.10 (-2.62%)
52 Week Range
$2.08–$4.58
View on NASDAQ

OraSure Technologies, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for OSUR

Select to highlight on chart
5 transactions
Compliance: 42%
Tom Malinowski23 Feb 20216 Mar 2021SaleStock$15,001 - $50,000N/A
Tom Malinowski23 Feb 202113 Aug 2022SaleStock$15,001 - $50,000N/A
Tom Malinowski11 Jan 20215 Mar 2021SaleStock$1,001 - $15,000N/A
Tom Malinowski11 Jan 202113 Aug 2022SaleStock$1,001 - $15,000N/A
Tom Malinowski9 Dec 202026 Aug 2021SaleStock$15,001 - $50,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$255.87M

Volume

355.98K

Beta

1.02

P/E Ratio

-5.38

Fundamentals

EPS

$-0.69

Div. Yield

-

Open

$3.77

Day Range

$3.71 – $3.79

Company Information

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ · USD
Country
US
CEO
Carrie Eglinton Manner
IPO Date
1986-11-17

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, E...

Earnings

Next Report

Q3 2026

4 Nov

EPS Est.

$-0.18

Rev. Est.

$31.1M

Days Until

20

Recent Quarters

Q2 20265 Aug
EPS$0.09
Beat 133.3%
Q1 20266 May
EPS$-0.32
Miss 39.1%
Q4 202525 Feb
EPS$-0.27
Miss 58.8%
Q3 20255 Nov
EPS$-0.19
Miss 18.8%
Q2 20255 Aug
EPS$-0.26
Miss 36.8%
Q1 20257 May
EPS$-0.18
Miss 20.0%
Q4 202425 Feb
EPS$-0.14
Miss 180.0%
Q3 20246 Nov
EPS$-0.06
Miss 50.0%
Q2 20246 Aug
EPS$-0.01
Miss 27.4%
Q1 20248 May
EPS$-0.05
Miss 225.0%
Q4 202327 Feb
EPS$0.27
Beat 200.0%
Q3 20237 Nov
EPS$0.15
Beat 114.3%
Q2 20233 Aug
EPS$-0.07
Miss 16.7%
Q1 202310 May
EPS$0.37
Beat 164.3%
Q4 202214 Feb
EPS$0.21
Beat 2200.0%
Q3 20228 Nov
EPS$0.07
Beat 275.0%
Q2 20229 Aug
EPS$-0.26
Miss 100.0%
Q1 202210 May
EPS$-0.28
Miss 103.0%
Q4 202123 Feb
EPS$-0.14
Miss 7.7%
Q3 20213 Nov
EPS$-0.21
Miss 425.0%
Q2 20213 Aug
EPS$-0.02
Miss 150.0%
Q1 20215 May
EPS$0.05
Beat 25.0%
Q4 20201 Mar
EPS$0.03
Miss 57.1%
Q3 20204 Nov
EPS$0.01
Beat 114.3%
Q2 20205 Aug
EPS$-0.16
Miss 77.8%
Q1 20206 May
EPS$-0.12
Miss 100.0%
Q4 201919 Feb
EPS$0.06
Miss 14.3%
Q3 20196 Nov
EPS$0.21
Beat 133.3%
Q2 20196 Aug
EPS$0.07
Beat 133.3%
Q1 20198 May
EPS$-0.05
Beat 16.7%
Q4 20186 Feb
EPS$0.18
Beat 63.6%
Q3 20187 Nov
EPS$0.13
Beat 18.2%
Q2 20188 Aug
EPS$0.07
Beat 75.0%
Q1 20182 May
EPS$-0.03
Beat 50.0%
Q4 20177 Feb
EPS$0.12
Beat 9.1%
Q3 20171 Nov
EPS$0.09
Beat 0.0%
Q2 20172 Aug
EPS$0.09
Beat 28.6%
Q1 20173 May
EPS$0.21
Beat 23.5%
Q4 20168 Feb
EPS$0.13
Beat 116.7%
Q3 20162 Nov
EPS$0.11
Beat 57.1%
Q2 20163 Aug
EPS$0.07
Beat 40.0%
Q1 20164 May
EPS$0.04
Beat 100.0%
Q4 20153 Feb
EPS$0.08
Beat 166.7%
Q3 20154 Nov
EPS$0.03
Beat 400.0%
Q2 20155 Aug
EPS$0.03
Beat 200.0%
Q1 20156 May
EPS$0.00
Beat 110.0%
Q4 20144 Feb
EPS$-0.05
Miss 25.0%
Q3 20145 Nov
EPS$0.02
Beat 140.0%
Q2 20146 Aug
EPS$-0.02
Beat 33.3%
Q1 20147 May
EPS$-0.10
Beat 23.1%
Q4 20135 Feb
EPS$-0.04
Beat 50.0%
Q3 20136 Nov
EPS$-0.03
Beat 70.0%
Q2 20137 Aug
EPS$-0.10
Beat 37.5%
Q1 20138 May
EPS$-0.18
Beat 0.0%
Q4 20126 Feb
EPS$-0.11
Beat 21.4%
Q3 20127 Nov
EPS$-0.04
Beat 50.0%
Q2 20127 Aug
EPS$-0.07
Beat 22.2%
Q1 20122 May
EPS$-0.08
Beat 0.0%
Q4 20118 Feb
EPS$0.02
Beat 140.0%
Q3 20112 Nov
EPS$-0.03
Beat 57.1%
Q2 20113 Aug
EPS$-0.05
Beat 28.6%
Q1 20114 May
EPS$-0.06
Beat 25.0%
Q4 20109 Feb
EPS$-0.02
Beat 75.0%
Q3 20109 Nov
EPS$0.01
Beat 125.0%
Q2 20104 Aug
EPS$-0.01
Beat 85.0%
Q1 20105 May
EPS$-0.05
Beat 16.7%
Q4 200910 Feb
EPS$-0.03
Beat 62.5%
Q3 20094 Nov
EPS$0.04
Beat 180.0%
Q2 20095 Aug
EPS$-0.05
Beat 16.7%
Q1 20096 May
EPS$-0.04
Beat 42.9%
Q4 200811 Feb
EPS$-0.64
Miss 611.1%
Q3 20085 Nov
EPS$-0.04
Beat 55.6%
Q2 20085 Aug
EPS$-0.05
Beat 28.6%
Q1 20086 May
EPS$0.04
Beat 33.3%
Q4 200712 Feb
EPS$0.00
Q3 200730 Oct
EPS$0.00
Miss 99.0%
Q2 200731 Jul
EPS$0.02
Beat 100.0%
Q1 20078 May
EPS$0.03
Beat 50.0%
Q4 200613 Feb
EPS$0.02
Beat 0.0%
Q3 20061 Nov
EPS$0.05
Beat 400.0%
Q2 20068 Aug
EPS$0.03
Beat 50.0%
Q1 20062 May
EPS$0.02
Beat 0.0%
Q4 20059 Feb
EPS$0.05
Beat 0.0%
Q3 20059 Nov
EPS$0.08
Beat 60.0%
Q2 20052 Aug
EPS$0.06
Beat 200.0%
Q1 20053 May
EPS$0.03
Q4 200410 Feb
EPS$-0.01
Beat 72.5%
Q3 20042 Nov
EPS$-0.01
Beat 34.0%
Q2 20043 Aug
EPS$0.00
Beat 132.0%
Q1 200427 Apr
EPS$-0.00
Beat 63.0%
Q4 200310 Feb
EPS$0.01
Miss 2.0%
Q3 200328 Oct
EPS$0.00
Beat 114.0%
Q2 200329 Jul
EPS$-0.01
Beat 54.0%
Q1 200329 Apr
EPS$-0.03
Beat 25.0%
Q4 20025 Feb
EPS$-0.00
Beat 85.2%
Q3 200228 Oct
EPS$-0.01
Beat 48.5%
Q2 200229 Jul
EPS$-0.03
Beat 25.0%
Q1 200230 Apr
EPS$-0.04
Beat 20.0%
Q4 200115 Feb
EPS$-0.06
Miss 100.0%
Q3 200124 Oct
EPS$0.00
Miss 98.0%
Q2 200127 Jul
EPS$-0.01
Q1 20011 May
EPS$-0.02
Miss 100.0%
Q1 20012 Apr
EPS$-0.10
Miss 900.0%
Q4 20001 Jan
EPS$-0.05
Miss 150.0%
Q3 20001 Oct
EPS$-0.06
Miss 700.0%
Q1 200025 Apr
EPS$-0.06
Q2 199930 Sept
EPS$-0.06
Q1 199930 Jun
EPS$-0.05
Q4 199831 Mar
EPS$-0.06
Q3 199831 Dec
EPS$-0.05
Q2 199830 Sept
EPS$-0.04
Q1 199830 Jun
EPS$-0.02
Q4 199731 Mar
EPS$-0.05
Q3 199731 Dec
EPS$-0.05
Q2 199730 Sept
EPS$-0.28
Q1 199730 Jun
EPS$-0.11
Q4 199631 Mar
EPS$-0.51
Q3 199631 Dec
EPS$-0.23
Q2 199630 Sept
EPS$-0.00
Q1 199630 Jun
EPS$0.17
Q4 199531 Mar
EPS$-0.10
Q3 199531 Dec
EPS$-0.09
Q2 199530 Sept
EPS$-0.29
Q1 199530 Jun
EPS$-0.23
Q4 199431 Mar
EPS$-0.27
Q3 199431 Dec
EPS$-0.26
Q2 199430 Sept
EPS$-0.28
Q1 199430 Jun
EPS$-0.24
Q4 199331 Mar
EPS$-0.31
Q3 199331 Dec
EPS$-0.21
Q2 199330 Sept
EPS$-0.27
Q1 199330 Jun
EPS$-0.25
Q4 199231 Mar
EPS$-0.35
Q3 199231 Dec
EPS$-0.23
Q2 199230 Sept
EPS$-0.18
Q1 199230 Jun
EPS$-0.12
Q4 199131 Mar
EPS$-0.12
Q3 199131 Dec
EPS$-0.13
Q2 199130 Sept
EPS$-0.15
Q1 199130 Jun
EPS$-0.09
Q4 199031 Mar
EPS$-0.11
Q3 199031 Dec
EPS$-0.07
Q2 199030 Sept
EPS$-0.04
Q1 199030 Jun
EPS$-0.11
Q4 198931 Mar
EPS$-0.08
Q3 198931 Dec
EPS$-0.05
Q2 198930 Sept
EPS$-0.05
Q1 198930 Jun
EPS$-0.07
Q4 198831 Mar
EPS$-0.10
Q3 198831 Dec
EPS$-0.12

5 politicians traded within 30 days

Dividends

Dividend History

8 Jan 1998
Amount $1.6000

Stock Splits

Split History

8 Apr 1987Stock Split
Ratio3:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about OSUR

Which members of Congress have traded OSUR?
1 member of Congress has disclosed 12 trade in OraSure Technologies, Inc. (OSUR) under the STOCK Act: Tom Malinowski.
When was OSUR most recently disclosed by Congress?
The most recent OSUR disclosure was a sale by Tom Malinowski on 23 February 2021.
What is the total disclosed congressional trading volume for OSUR?
Members of Congress have disclosed approximately $292K in OSUR sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in OSUR?
This OSUR page updates as soon as new STOCK Act disclosures are filed for OraSure Technologies, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.